STRATA Skin Sciences, Inc.

NasdaqCM:SSKN Stock Report

Market Cap: US$12.3m

STRATA Skin Sciences Balance Sheet Health

Financial Health criteria checks 3/6

STRATA Skin Sciences has a total shareholder equity of $9.3M and total debt of $15.2M, which brings its debt-to-equity ratio to 162.2%. Its total assets and total liabilities are $40.2M and $30.9M respectively.

Key information

162.2%

Debt to equity ratio

US$15.15m

Debt

Interest coverage ration/a
CashUS$7.06m
EquityUS$9.34m
Total liabilitiesUS$30.86m
Total assetsUS$40.21m

Recent financial health updates

Recent updates

Investors Don't See Light At End Of STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Tunnel And Push Stock Down 30%

Aug 18
Investors Don't See Light At End Of STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Tunnel And Push Stock Down 30%

Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?

Aug 07
Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?

STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Shares Lagging The Industry But So Is The Business

Jun 07
STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Shares Lagging The Industry But So Is The Business

Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?

Mar 19
Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?

STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Dec 31
STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?

Nov 03
Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?

We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt

Jul 04
We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Stock Rockets 26% But Many Are Still Ignoring The Company

Apr 18
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Stock Rockets 26% But Many Are Still Ignoring The Company

Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?

Jan 14
Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?

STRATA Skin Sciences GAAP EPS of -$0.05 in-line, revenue of $9.1M beats by $0.96M

Aug 10

Strata Skin stock soars ~18% after hours on U.S. commercial launch of acne treatment

Jul 25

What Type Of Returns Would STRATA Skin Sciences'(NASDAQ:SSKN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 09
What Type Of Returns Would STRATA Skin Sciences'(NASDAQ:SSKN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Reflecting on STRATA Skin Sciences' (NASDAQ:SSKN) Share Price Returns Over The Last Five Years

Nov 24
Reflecting on STRATA Skin Sciences' (NASDAQ:SSKN) Share Price Returns Over The Last Five Years

Financial Position Analysis

Short Term Liabilities: SSKN's short term assets ($15.9M) exceed its short term liabilities ($14.0M).

Long Term Liabilities: SSKN's short term assets ($15.9M) do not cover its long term liabilities ($16.8M).


Debt to Equity History and Analysis

Debt Level: SSKN's net debt to equity ratio (86.6%) is considered high.

Reducing Debt: SSKN's debt to equity ratio has increased from 26% to 162.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SSKN has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: SSKN has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 49.3% each year.


Discover healthy companies